Heart failure with systolic function preserved from infiltrative etiology. the silent enemy

Authors

  • Juan Carlos Gómez Polo Cardiovascular Imaging Unit. Cardiology Service. San Carlos Clinical University Hospital. Madrid. Spain
  • Carolina Espejo Paeres Cardiovascular Imaging Unit. Cardiology Service. San Carlos Clinical University Hospital. Madrid. Spain
  • Leopoldo Pérez de Isla Cardiovascular Imaging Unit. Cardiology Service. San Carlos Clinical University Hospital. Madrid. Spain

DOI:

https://doi.org/10.37615/retic.n1a14

Keywords:

Diastolic dysfunction, Restrictive cardiomyopathy, Amyloidosis.

Abstract

Heart failure with preserved ejection fraction still remains being one of the paradigms of modern Cardiology. Reaching the correct diagnosis and identifying the etiology is a diffi cult challenge, where the new techniques of strain rate may develop an important role. In therms of medical therapies, there is a lack of specific measures in order to improve the prognosis of these patients. Our clinical report tries to show the clinical situation and echocardiographic patterns that must establish the suspicion of cardiac amyloidosis.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Senni M, Tribouilly CM, Rodeheff er RJ, Jacobsen SJ, Evans JM, Bailey KR, et al. Congestive heart failure in the community. A study of all incident cases in Olmsted County, Minnesota, in 1991. Circulation 1998; 98: 282- 289. DOI: https://doi.org/10.1161/01.CIR.98.21.2282

Yusuff S, Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ et al. for the CHARM Investigators and Committees. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: The CHARM-Preserved Trial. Lancet 2003; 362: 777- 781. DOI: https://doi.org/10.1016/S0140-6736(03)14285-7

Rodríguez-Artalejo F, Guallar-Castillón P, Banegas-Banegas JR, Del Rey-Calero J. Trends in hospitalization and mortality for heart failure in Spain, 1980- 1993. Eur Heart J 1997; 18: 1.771-1.779. DOI: https://doi.org/10.1093/oxfordjournals.eurheartj.a015172

European Study Group on Diastolic Heart Failure. How to diagnose diastolic heart failure. Eur Heart J 1998; 19 (7): 990-1003. DOI: https://doi.org/10.1053/euhj.1998.1057

Falk RH. Diagnosis and management of the cardiac amyloidoses. Circulation 2005; 112: 2.047-2.060. DOI: https://doi.org/10.1161/CIRCULATIONAHA.104.489187

Abdalla I, Murray RD, Lee JC, Stewart WJ, Tajik AJ, Klein AL. Duration of pulmonary venous atrial reversal fl ow velocity and mitral infl ow a wave: New measure of severity of cardiac amyloidosis. J Am Soc Echocardiogr 1998; 11: 1.125-1.133. DOI: https://doi.org/10.1016/S0894-7317(98)80007-2

Koyama J, Falk RH. Prognostic signifi cance of strain Doppler imaging in light-chain amyloidosis. JACC Cardiovasc Imaging 2010; 3 (4): 333-342. DOI: https://doi.org/10.1016/j.jcmg.2009.11.013

Published

2016-04-30

How to Cite

1.
Gómez Polo JC, Espejo Paeres C, Pérez de Isla L. Heart failure with systolic function preserved from infiltrative etiology. the silent enemy. Rev Ecocardiogr Pract Otras Tec Imag Card (RETIC) [Internet]. 2016 Apr. 30 [cited 2024 Jul. 3];(1):57-60. Available from: https://imagenretic.org/RevEcocarPract/article/view/489